Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

Journal of Hepatology

Volumn 35, Issue 3, 2001, Pages 376-385

  Paizis, Georgina ^a   Gilbert, Richard E ^a   Cooper, Mark E ^a   Murthi, Padma ^a   Schembri, Josefa M ^a   Wu, Leonard L ^a   Rumble, Jonathan R ^a   Kelly, Darren J ^a   Tikellis, Christos ^a   Cox, Alison ^a   Smallwood, Richard A ^a   Angus, Peter W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin; Angiotensin type 1 receptor; Collagen; Fibrosis; ig h3; Liver; Renin angiotensin system; Transforming growth factor ;

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN; HYDROXYPROLINE; IRBESARTAN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROGENESIS; GENE EXPRESSION; GENE LOCATION; IN SITU HYBRIDIZATION; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

ANGIOTENSIN II; ANIMALS; COLLAGEN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034849945     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00146-5     Document Type: Article

References (56)

1. Transforming growth factor beta in tissue fibrosis
2. Fibrosis, a common pathway to organ failure: Angiotensin II and tissue repair
3. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
4. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
5. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells
6. Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats
7. Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart
8. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat
9. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues
10. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis
11. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
12. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
13. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
14. Angiotensin II induces contraction and proliferation of human hepatic stellate cells
15. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats
16. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat
17. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
18. Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver
19. Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis
20. New spectrophotometric method for the determination of proline in tissue hydrolyzates
21. Regression of hepatic lesions after treatment of Schistosoma mansoni or Schistosoma japonicum infection in mice: A comparative study
22. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. Ontogeny of aquaporins 1 and 3 in ovine placenta and fetal membranes
25. Increased epidermal growth factor in experimental diabetes related kidney growth in rats
26. Fundamentals of quantitative autoradiography by computer densitometry for in situ hybridization, with emphasis on 33P
27. Statistical methods
28. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts
29. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy
30. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart
31. Successful detection by in situ cDNA hybridization of three members of the serpin family: Angiotensinogen, alpha 1 protease inhibitor, and antithrombin III in human hepatocytes
32. Expression of renin in the rat liver
33. Localization of cathepsin D in rat liver. Immunocytochemical study using post-embedding immunoenzyme and protein A-gold techniques
34. The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G
35. Angiotensin II receptors
36. Enhanced granuloma angiotensin I converting enzyme activity associated with modulation in murine schistosomiasis
37. Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis
38. Host genetic factors influence disease progression in chronic hepatitis C
39. Angiotensin II in renal fibrosis: Should TGF-beta rather than blood pressure be the therapeutic target?
40. Transforming growth factor-beta 1: There is regulation beyond transcription
41. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis
42. TGF-beta1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis
43. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat
44. Role of transforming growth factor beta in human disease
45. Expression of different isoforms of TGF-beta and the latent TGF-beta binding protein (LTBP) by rat Kupffer cells
46. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions
47. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products
48. The emerging role of transforming growth factor-beta in kidney diseases
49. Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts
50. Angiotensin II upregulates transforming growth factor-beta type 1 receptor on rat vascular smooth muscle cells
51. Angiotensin II induces TGF-beta 1 production in rat heart endothelial cells
52. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
53. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis
54. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis
55. Renoprotective effects of angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
56. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis